• Aucun résultat trouvé

Postmenopausal women

Ultrasound-based estimates of cortical bone thickness and porosity are associated with non-traumatic fractures in postmenopausal women: A pilot study

Ultrasound-based estimates of cortical bone thickness and porosity are associated with non-traumatic fractures in postmenopausal women: A pilot study

... Abstract Recent ultrasound axial transmission techniques exploit the multimode waveguide re- sponse of long bones to yield estimates of cortical bone structure characteristics. This pi- lot cross-sectional study aimed to ...

54

Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis: Treatment of Peripheral Osteoporosis (TROPOS) study

Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis: Treatment of Peripheral Osteoporosis (TROPOS) study

... Ambulatory postmenopausal women were recruited at 75 centers in 11 European countries and in ...Australia. Women were eligible in the study: 1) if they had a femoral neck bone mineral density (BMD) ...

7

Hereditary Angioedema with and Without C1-Inhibitor Deficiency in Postmenopausal Women

Hereditary Angioedema with and Without C1-Inhibitor Deficiency in Postmenopausal Women

... of postmenopausal women with HAE from 13 sites of the National Angioedema Reference Center ...All postmenopausal patients with type I or II C1-INH-HAE, or nC1-INH-HAE with a F12 mutation, another ...

9

Estimated numbers of postmenopausal women treated by hormone therapy in France.

Estimated numbers of postmenopausal women treated by hormone therapy in France.

... healthy postmenopausal women aged 50–79 years, with an intact uterus, to combined conjugated equine estrogens plus progestogen or ...hysterectomized women received estrogens ...of women aged ...

12

Flavanones protect from arterial stiffness in postmenopausal women consuming grapefruit juice for 6 mo: a randomized, controlled, crossover trial

Flavanones protect from arterial stiffness in postmenopausal women consuming grapefruit juice for 6 mo: a randomized, controlled, crossover trial

... Several limitations should be acknowledged in the present study. Special attention was paid to match the CD to GFJ as closely as possible for a range of components, but we cannot fully exclude the possibility that other ...

9

Effect of Cardiorespiratory Fitness on Vascular Regulation and Oxidative Stress in Postmenopausal Women

Effect of Cardiorespiratory Fitness on Vascular Regulation and Oxidative Stress in Postmenopausal Women

... sedentary postmenopausal women was partially restored by infusion of ascorbic ...exercise-trained postmenopausal and premenopausal ...in postmenopausal-related oxidative ...and ...

7

Previous oral contraceptive use and breast cancer risk according to hormone replacement therapy use among postmenopausal women.

Previous oral contraceptive use and breast cancer risk according to hormone replacement therapy use among postmenopausal women.

... in postmenopausal women who never used HRT probably due to lack of statistical ...susceptible women would in fact have already developed breast cancer and consequently were not included in our study ...

11

Activated protein C resistance among postmenopausal women using transdermal estrogens: importance of progestogen.

Activated protein C resistance among postmenopausal women using transdermal estrogens: importance of progestogen.

... to women with hyperestrogenic symptoms (endometrial susceptibility, benign breast diseases, …) ...among postmenopausal women [38], women with stronger estrogenic climate would be more likely ...

19

Treatment of postmenopausal women with osteoporosis for 5 years with denosumab : two-year results from the FREEDOM trial extension

Treatment of postmenopausal women with osteoporosis for 5 years with denosumab : two-year results from the FREEDOM trial extension

... Centro TIEMPO, Buenos Aires, Argentina; 9 Center for Bone Research at the Sahlgrenska Academy, Goteburg, Sweden; 10 Hospital de Clinicas da Universidade Federal do Parana, Curitiba, Brazil; 11 Univ. of Liege, Belgium; 12 ...

1

Hormone therapy and risk of venous thromboembolism among postmenopausal women

Hormone therapy and risk of venous thromboembolism among postmenopausal women

... Conflict of interest: The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper References [1] Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, ...

10

Additive effects of raloxifene and alendronate on bone density and biochemical markers of bone remodeling in postmenopausal women with osteoporosis

Additive effects of raloxifene and alendronate on bone density and biochemical markers of bone remodeling in postmenopausal women with osteoporosis

... in postmenopausal women with ...331 postmenopausal women with osteoporosis (femoral neck BMD T-score, less than ...ⴚ2). Women (aged <75 yr; >2 yr since their last menstrual ...

8

Recent Recreational Physical Activity and Breast Cancer Risk in Postmenopausal Women in the E3N Cohort

Recent Recreational Physical Activity and Breast Cancer Risk in Postmenopausal Women in the E3N Cohort

... (13), women who were active close to menopause but not later did not have a lower risk of breast cancer than the least active women (<9 MET-h/week) during both peri- ods, whereas women who were ...

11

Milk polar lipids reduce lipid cardiovascular risk factors in overweight postmenopausal women: towards a gut sphingomyelin-cholesterol interplay

Milk polar lipids reduce lipid cardiovascular risk factors in overweight postmenopausal women: towards a gut sphingomyelin-cholesterol interplay

... in postmenopausal women at risk for CVD and the second was a proof- of- principle investigation of acute consumption of PL- enriched cheeses in ileostomy ...

16

Milk polar lipids favorably alter circulating and intestinal ceramide and sphingomyelin species in postmenopausal women

Milk polar lipids favorably alter circulating and intestinal ceramide and sphingomyelin species in postmenopausal women

... Milk polar lipids favorably alter circulating and intestinal ceramide and sphingomyelin species in postmenopausal women... ceramide and sphingomyelin species in postmenopausal women.[r] ...

43

Milk polar lipids reduce lipid cardiovascular risk factors in overweight postmenopausal women: towards a gut sphingomyelin-cholesterol interplay

Milk polar lipids reduce lipid cardiovascular risk factors in overweight postmenopausal women: towards a gut sphingomyelin-cholesterol interplay

... Methods: We performed a double-blind randomized controlled trial in 58 postmenopausal women with fasting HDL-cholesterol < 1.6 mM. They were subjected to a 4-week dietary intervention with daily ...

1

Hormone replacement therapy and risk of venous thromboembolism in postmenopausal women: systematic review and meta-analysis.

Hormone replacement therapy and risk of venous thromboembolism in postmenopausal women: systematic review and meta-analysis.

... w19 G. L. Anderson, M. Limacher, A. R. Assaf, T. Bassford, S. A. Beresford, H. Black, D. Bonds, R. Brunner, R. Brzyski, B. Caan, R. Chlebowski, D. Curb, M. Gass, J. Hays, G. Heiss, S. Hendrix, B. V. Howard, J. Hsia, A. ...

35

Strontium ranelate reduces the risk of vertebral fractures in osteoporotic postmenopausal women whatever the baseline vertebral fractures status

Strontium ranelate reduces the risk of vertebral fractures in osteoporotic postmenopausal women whatever the baseline vertebral fractures status

... 5082 women receiving strontium ranelate 2g/day orally or placebo plus calcium/vitaminD in both groups during 3 ...5082 women, 2605 had no prevalent vertebral fracture (1320 in strontium ranelate group ...

1

The effect of tibolone in postmenopausal women receiving tamoxifen after surgery for breast cancer: a randomised, double-blind, placebo-controlled trial

The effect of tibolone in postmenopausal women receiving tamoxifen after surgery for breast cancer: a randomised, double-blind, placebo-controlled trial

... DISCUSSION In this study, we have demonstrated that tibolone prevented the increase in the occurrence, severity and intensity of hot flushes and sweats associated with tamoxifen treatment following surgical treatment for ...

8

Plasma estrogen levels, estrogen receptor gene variation, and ischemic arterial disease in postmenopausal women: the three-city prospective cohort study.

Plasma estrogen levels, estrogen receptor gene variation, and ischemic arterial disease in postmenopausal women: the three-city prospective cohort study.

... of postmenopausal women using hormone therapy, a random subcohort of 533 women and 105 incident cases of first IAD events over 4-year of follow-up were ...

30

Hormone therapy and hemostasis among postmenopausal women: a review.

Hormone therapy and hemostasis among postmenopausal women: a review.

... 48, 49 . Nevertheless, the biological mechanism for such APC resistance in postmenopausal women using oral estrogens remains largely not understood. Some studies have found that changes in levels of protein ...

30

Show all 609 documents...

Sujets connexes